foxo4-dri senolytic 2023 2024 study The disordered p53 transactivation domain is the target of FOXO4 and the compound foxo4-dri peptide senolytic mouse study
foxo4 dri peptide senolytic mouse study 2023 2024 Molecular modelling of the FOXO4 TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4 DRI Peptide for Cellular Senolytics: charting a new course or enhancing existing anti tumor therapies? Cellular Oncology Springer Nature Link Senescence Inducers and Senolytics Pathways and Drugs Targeting Cellular Senescence[v1] Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect
Pay in 4 interest-free payments of $7.28 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13



